Home Industry events Industry events Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Industry OCT DACH Date 3 November 2026 - 4 November 2026 Time 08:00 - 18:00 Location Basel, Switzerland Timezone Europe/Zurich ICON will exhibit | Booth #6 Industry AASLD Date 5 November 2026 - 9 November 2026 Time 08:00 - 18:00 Location Denver, CO, USA Timezone MDT - America/Denver ICON will exhibit | Booth #1861 Industry ISPOR EU Date 8 November 2026 - 11 November 2026 Time 08:00 - 18:00 Location Vienna, Austria Timezone Europe/Vienna ICON will exhibit | Booth #1615 Industry Obesity Week 2026 Date 14 November 2026 - 17 November 2026 Time 08:00 - 18:00 Location Washington DC, USA Timezone EDT - America/New York ICON will exhibit | Booth #212 Industry EBF Date 17 November 2026 - 19 November 2026 Time 08:00 - 18:00 Location Barcelona, Spain Timezone Europe/Madrid ICON will exhibit and speak | Booth #B1 Industry SCDM India Date 3 December 2026 - 5 December 2026 Time 08:00 - 18:00 Location Bengaluru, India Timezone IST - Asia/Kolkata ICON will exhibit and speak In this section In this section Awards Events Industry events ASCO 2026 ISPOR EU 2026 Webinars Workshops In the News Mediakit Facts and figures ICON spokespeople Press releases Social media hub Webinars Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Event Webinars Event Workshops What’s happening in ICON ICON Plc Advancing an asset towards human studies but not there yet? Stop by ICON Booth \#1861 and speak with one of our drug development scientists. Learn how we approach development and how our nonclinical, CMC, and regulatory ... 30 Oct View post View webpage ICON Plc When a data issue is closed, how do you know it’s really been resolved? Join Shabeeb Kannattikuni at the PHUSE Single Day Event in North Carolina, where he’ll share a SAS-based solution to checking data issue resolution... 30 Oct View post View webpage ICON Plc Successful obesity trials depend on reaching and engaging the right patients. At #ObesityWeek, visit ICON at booth \#212 to explore recruitment expertise and retention-focused strategies designed to support long-term eng... 29 Oct View post View webpage ICON Plc Creativity can be a powerful way to connect and understand different perspectives. To recognise Invisible Disabilities Awareness, 62 colleagues came together at our Mexico City office for a watercolour workshop focused ... 29 Oct View post ICON Plc Congress participation decisions made easier. Meetings are expensive, arrangements are time consuming. With 50+ data fields to compare details, PubsHub Journals & Congresses makes your decision making faster and easier. ... 29 Oct View post View webpage ICON Plc The 2028 milestone Orphan medicinal products will come under JCA rules in January 2028, with all remaining medicines following by 2030. For sponsors already in phase 2, the decisions made today could shape future Europea... 29 Oct View post View webpage ICON Plc The questions facing healthcare decision-makers are becoming increasingly complex. How do we generate better evidence? Measure outcomes more effectively? Apply AI responsibly? Ensure patient perspectives are reflected? J... 29 Oct View post View webpage ICON Plc ICON will attend the 19th EBF Open Symposium, taking place from 17–19 November at the Hyatt Regency Barcelona Tower. Join us at booth #B1 to meet our experts and learn how ICON delivers high-quality bioanalytical soluti... 28 Oct View post View webpage ICON Plc In cell and gene therapy, the unit of supply is no longer simply a vial. It is an interconnected journey involving the patient, product, place, time, condition and decision status. At IRT & RTSM 2026, ICON’s Alyssa Gill... 28 Oct View post View webpage ICON Plc ICON is looking forward to once again attending the #OCTDACH conference on 3–4 November at the Congress Center in Basel, Switzerland. We invite you to visit us at booth \#6 to learn how we can help you navigate complex... 27 Oct View post View webpage ICON Plc Often, COA decisions are made too late, with endpoint selection, validation, and global deployment treated as separate activities rather than components of a single early-stage COA strategy. Join our upcoming webinar t... 27 Oct View post View webpage ICON Plc Because patients can’t wait, every rare disease development decision matters. Meet ICON at World Orphan Drug Congress Europe, booth \#313, to discuss how our integrated development and regulatory strategy, patient advoca... 27 Oct View post
